随着《新药审批办法》的修改实施，化学药物的研究困难重重，中药新药的研究开发已逐渐成为医药界所关注的热点，我国实现“２０００年人人享有初级卫生保健”和防治当今世界医学疑难病症都离不开中医药，但当前中药新药研究低水平重复现象严重用此，对于从事中药新药研究开发的企业和科研单位来说，新药选题与其面临的市场定位至关重要。本文结合我国当前人口疾病模式及地区特点，在这方面提出了一些建议，以供参考。

With the revision and implementation of" Measures Concerning the Examination and Approval of New Pharmaceuticals", and in view of the difficulties encountered by the research of chemical medicines, the research and development of new products of CMM have become the focus of attention in medical and pharmaceutical circles. To the policy that in 2000 the whole Chinese nation will enjoy elementary health care , and to the practice of preventing and curing the difficult and complicated cases of illness, traditional Chinese medicine is undoubtedly indispensable. In view of the serious situation where the research on new products of CMM is being repeated at low levels, it is very important for the pharmaceutical enterprises and research institutions to be wise and careful in selecting subjects and orienting markets for new products. Based on the prevailing disease types and regional features in China, the paper puts forward a number of suggestions for reference.